DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats

BACKGROUND: Hyperglycemia and insulin resistance often develop cardiovascular and nephrological dysfunction in diabetic patients. Sitagliptin is used to treat diabetes and showed potential benefit in lowering increased blood glucose level in diabetes. This investigation reports the effect of sitagli...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetol Metab Syndr
Asıl Yazarlar: Alam, Md. Ashraful, Chowdhury, Mohammed Riaz Hasan, Jain, Preeti, Sagor, Md. Abu Taher, Reza, Hasan Mahmud
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2015
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4658771/
https://ncbi.nlm.nih.gov/pubmed/26609328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-015-0095-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller